Hereditary pancreatic cancer

A clinical perspective

Julia B. Greer, Henry T. Lynch, Randall E. Brand

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Pancreatic cancer is an extraordinarily deadly disease and is responsible for over 220,000 deaths worldwide each year. One of the greatest risk factors for developing pancreatic cancer is a positive family history. Hereditary pancreatitis patients have a greatly elevated pancreatic cancer risk and individuals with cystic fibrosis may rarely develop this cancer, but often at very young ages. Various genetically linked cancer syndromes have been associated with pancreatic cancer in mutation-positive family members. Finally, familial pancreatic cancer-defined as families with two or more first-degree relatives who have pancreatic cancer but do not have a known cancer syndrome-is a known entity whose disease-causing mutation remains unidentified. This article describes research to date on hereditary pancreatic cancer, addresses how best clinicians should recognise hereditary forms of pancreatic cancer and explains the emotional burden of discovering a potentially lethal mutation. Many controversies and unanswered questions in hereditary pancreatic cancer remain.

Original languageEnglish
Pages (from-to)159-170
Number of pages12
JournalBailliere's Best Practice and Research in Clinical Gastroenterology
Volume23
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Pancreatic Neoplasms
Mutation
Neoplasms
Cystic Fibrosis
Research

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Hereditary pancreatic cancer : A clinical perspective. / Greer, Julia B.; Lynch, Henry T.; Brand, Randall E.

In: Bailliere's Best Practice and Research in Clinical Gastroenterology, Vol. 23, No. 2, 04.2009, p. 159-170.

Research output: Contribution to journalArticle

@article{3ac19102447643ee871a825a0d4f9cda,
title = "Hereditary pancreatic cancer: A clinical perspective",
abstract = "Pancreatic cancer is an extraordinarily deadly disease and is responsible for over 220,000 deaths worldwide each year. One of the greatest risk factors for developing pancreatic cancer is a positive family history. Hereditary pancreatitis patients have a greatly elevated pancreatic cancer risk and individuals with cystic fibrosis may rarely develop this cancer, but often at very young ages. Various genetically linked cancer syndromes have been associated with pancreatic cancer in mutation-positive family members. Finally, familial pancreatic cancer-defined as families with two or more first-degree relatives who have pancreatic cancer but do not have a known cancer syndrome-is a known entity whose disease-causing mutation remains unidentified. This article describes research to date on hereditary pancreatic cancer, addresses how best clinicians should recognise hereditary forms of pancreatic cancer and explains the emotional burden of discovering a potentially lethal mutation. Many controversies and unanswered questions in hereditary pancreatic cancer remain.",
author = "Greer, {Julia B.} and Lynch, {Henry T.} and Brand, {Randall E.}",
year = "2009",
month = "4",
doi = "10.1016/j.bpg.2009.02.001",
language = "English",
volume = "23",
pages = "159--170",
journal = "Bailliere's Best Practice and Research in Clinical Gastroenterology",
issn = "1521-6918",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - Hereditary pancreatic cancer

T2 - A clinical perspective

AU - Greer, Julia B.

AU - Lynch, Henry T.

AU - Brand, Randall E.

PY - 2009/4

Y1 - 2009/4

N2 - Pancreatic cancer is an extraordinarily deadly disease and is responsible for over 220,000 deaths worldwide each year. One of the greatest risk factors for developing pancreatic cancer is a positive family history. Hereditary pancreatitis patients have a greatly elevated pancreatic cancer risk and individuals with cystic fibrosis may rarely develop this cancer, but often at very young ages. Various genetically linked cancer syndromes have been associated with pancreatic cancer in mutation-positive family members. Finally, familial pancreatic cancer-defined as families with two or more first-degree relatives who have pancreatic cancer but do not have a known cancer syndrome-is a known entity whose disease-causing mutation remains unidentified. This article describes research to date on hereditary pancreatic cancer, addresses how best clinicians should recognise hereditary forms of pancreatic cancer and explains the emotional burden of discovering a potentially lethal mutation. Many controversies and unanswered questions in hereditary pancreatic cancer remain.

AB - Pancreatic cancer is an extraordinarily deadly disease and is responsible for over 220,000 deaths worldwide each year. One of the greatest risk factors for developing pancreatic cancer is a positive family history. Hereditary pancreatitis patients have a greatly elevated pancreatic cancer risk and individuals with cystic fibrosis may rarely develop this cancer, but often at very young ages. Various genetically linked cancer syndromes have been associated with pancreatic cancer in mutation-positive family members. Finally, familial pancreatic cancer-defined as families with two or more first-degree relatives who have pancreatic cancer but do not have a known cancer syndrome-is a known entity whose disease-causing mutation remains unidentified. This article describes research to date on hereditary pancreatic cancer, addresses how best clinicians should recognise hereditary forms of pancreatic cancer and explains the emotional burden of discovering a potentially lethal mutation. Many controversies and unanswered questions in hereditary pancreatic cancer remain.

UR - http://www.scopus.com/inward/record.url?scp=65149102081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65149102081&partnerID=8YFLogxK

U2 - 10.1016/j.bpg.2009.02.001

DO - 10.1016/j.bpg.2009.02.001

M3 - Article

VL - 23

SP - 159

EP - 170

JO - Bailliere's Best Practice and Research in Clinical Gastroenterology

JF - Bailliere's Best Practice and Research in Clinical Gastroenterology

SN - 1521-6918

IS - 2

ER -